Sutro Biopharma Inc (STRO)
3.83
-0.11
(-2.79%)
USD |
NASDAQ |
May 03, 16:00
3.84
+0.01
(+0.26%)
After-Hours: 20:00
Sutro Biopharma Max Drawdown (5Y): 92.48% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 92.48% |
| March 31, 2024 | 92.48% |
| February 29, 2024 | 92.48% |
| January 31, 2024 | 92.48% |
| December 31, 2023 | 92.48% |
| November 30, 2023 | 92.48% |
| October 31, 2023 | 90.70% |
| September 30, 2023 | 88.05% |
| August 31, 2023 | 87.62% |
| July 31, 2023 | 87.62% |
| June 30, 2023 | 87.62% |
| May 31, 2023 | 87.62% |
| April 30, 2023 | 87.62% |
| March 31, 2023 | 87.62% |
| February 28, 2023 | 87.62% |
| January 31, 2023 | 87.62% |
| December 31, 2022 | 87.62% |
| November 30, 2022 | 87.62% |
| October 31, 2022 | 87.62% |
| September 30, 2022 | 87.62% |
| August 31, 2022 | 87.62% |
| July 31, 2022 | 87.62% |
| June 30, 2022 | 87.62% |
| May 31, 2022 | 84.20% |
| April 30, 2022 | 78.18% |
| Date | Value |
|---|---|
| March 31, 2022 | 71.75% |
| February 28, 2022 | 70.04% |
| January 31, 2022 | 63.73% |
| December 31, 2021 | 59.28% |
| November 30, 2021 | 59.28% |
| October 31, 2021 | 59.28% |
| September 30, 2021 | 59.28% |
| August 31, 2021 | 59.28% |
| July 31, 2021 | 59.28% |
| June 30, 2021 | 59.28% |
| May 31, 2021 | 59.28% |
| April 30, 2021 | 59.28% |
| March 31, 2021 | 59.28% |
| February 28, 2021 | 59.28% |
| January 31, 2021 | 59.28% |
| December 31, 2020 | 59.28% |
| November 30, 2020 | 59.28% |
| October 31, 2020 | 59.28% |
| September 30, 2020 | 59.28% |
| August 31, 2020 | 59.28% |
| July 31, 2020 | 59.28% |
| June 30, 2020 | 59.28% |
| May 31, 2020 | 59.28% |
| April 30, 2020 | 59.28% |
| March 31, 2020 | 59.28% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
42.83%
Minimum
May 2019
92.48%
Maximum
Nov 2023
69.74%
Average
59.28%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| AnaptysBio Inc | 92.08% |
| ABVC BioPharma Inc | 99.79% |
| Reviva Pharmaceuticals Holdings Inc | -- |
| Flora Growth Corp | -- |
| Journey Medical Corp | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -33.58 |
| Beta (5Y) | 1.090 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 69.78% |
| Historical Sharpe Ratio (5Y) | -0.3072 |
| Historical Sortino (5Y) | -0.6199 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 28.52% |